Summary
Updated Aug 31, 2026
Robert W. Postma is Director of Alaunos Therapeutics, Inc. (TCRT). 7 SEC Form 4 filings on record going back to 2025, most recently on 27 July 2026. Lifetime open-market purchases: $5K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
7Every recent SEC Form 4 transaction Robert W. Postma has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 67% |
| Avg 5-day return | -6.12% |
| Avg 30-day return | -14.72% |
| Avg 90-day return | +29.47% |
| Best 30-day return | -2.40% |
Trading Pattern
InsiderAlpha's records for Robert W. Postma go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. The typical open-market purchase is $2K (3 buys totaling $5K). The largest single buy on record is $3K of TCRT in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Robert W. Postma. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jaime Vieser - $1K of TCRT open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Robert W. Postma?
Robert W. Postma is a corporate insider, tracked as Director of Alaunos Therapeutics, Inc. (TCRT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert W. Postma submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Robert W. Postma been buying or selling stock?
Recorded transactions: 3 open-market purchases ($5K) and 0 open-market sales across all tracked filings.
How accurate is Robert W. Postma's historical track record?
Across 3 tracked purchases, Robert W. Postma averaged -14.7% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Robert W. Postma's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Robert W. Postma and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial